Joined July 2017
15 Photos and videos
Dr. Michael Garshick retweeted
Starting tomorrow! 🫀🔥 Follow #CVinflame2026 Dr. Rafael Toro (@RafaelEToroM), CardioNerds Conference Scholar, for live updates from the 6th Annual North American #CardioRheum Symposium. Still need to register? ⤵️ nyulmc.org/cvinflammationcme @CardioNerds @garshick @Bweber04

Tomorrow is the day! The 6th Annual Cardiometabolic Risk in Inflammatory Conditions Symposium is here. Stay tuned for live highlights and key takeaways! #CVinflame2026 @NYUCVDPrevent @garshick @Bweber04 @CardioNerds
4
7
802
Dr. Michael Garshick retweeted
🔎Spotlight on Sjögren’s at our #CardioRheumatology CME! Sjögren’s expert Teja Kapoor, MD will review the comprehensive systemic and cardiovascular manifestations of Sjögren’s. Sign up here ⤵️ nyulmc.org/cvinflammationcme
3
9
1,397
Dr. Michael Garshick retweeted
🥊 It’s debate ⏰ time. See top 🫀 cardiology minds go head-to-head on today’s toughest questions at #HeartofCardio 2026 in Miami Beach. 🔗 heartofcardio.com/ Join dream team: @ba_steinberg | @ChiadiNdumele | @MCoylewright | @AJBloodMD | @manesh_patelMD | @HeartDocSadiya | @garshick
2
3
898
Dr. Michael Garshick retweeted
Check out the latest review in the Jan 16th issue of @CircRes by @IntmedAbel & colleagues "A Road Map to Understanding #CVD in #Diabetes" at ahajrnls.org/4b6JCJg @SaumyaDas_Lab @naomihamburg @ChiaraGiannare1 @jdnewmanMDMPH @lab_ej @ddbergMD @garshick
21
44
3,692
Dr. Michael Garshick retweeted
Excited to share our @JACCJournals #JACCIMG paper led by ⭐️@Bweber04 on AI detection of CAC on chest CT among 2,546 individuals with IMID (SLE/RA/Psoriasis) who did not have hx of ASCVD ~50% had CAC --> most not on statin! ➡️Over 8 yrs, AI CAC provided robust a/w MACE ACM
5
28
90
16,103
Dr. Michael Garshick retweeted
How do statins enhance endothelial health & reduce #inflammation? Dr. Michael Garshick will present important findings from the Cardiometabolic Health Strategically Focused Research Network. Mon, 11/10, 11:06-11:11 AM Basic Sci Zone Moderated Digital Poster 26: VB.MDP.16
2
5
244
Dr. Michael Garshick retweeted
Register for the 5th Annual #CardioRheum symposium and get free access to Medscape’s 1 hour mini-symposium: ‘Race Against Inflammation: ASCVD & #CKD Risk Reduction Insights.’ Join in-person or virtually—don’t miss the main event bonus content! Sign up: nyulmc.org/cvinflammationcme
7
11
852
Dr. Michael Garshick retweeted
2/Psoriasis is a skin disease that causes inflammation, and it’s been linked to heart problems. Michael Garshick, MD, director of the Cardio-Rheumatology Program, explores how inflammation in psoriasis may promote plaque buildup in arteries. 📍Sat, 11AM CT | Session 1041
1
2
7
364
Dr. Michael Garshick retweeted
NYU Langone cardiology faculty kick off #ACC25 in style! Stay tuned for exciting conference updates from @nyugrossman, highlighting the latest in #cardiovascular research and innovation.
4
43
2,158
Dr. Michael Garshick retweeted
👉Two great manuscripts about inflammation and CVD 🔓Open Access 1️⃣Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases ☝️This review summarizes the main characteristics and findings of completed and upcoming randomized controlled trials directly targeting inflammation in CVDs, and discusses major challenges and future perspectives in the exciting and constantly expanding landscape of cardioimmunology ahajournals.org/doi/full/10.… 2️⃣ Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay ☝️ This review aims to critically evaluate the current understanding of the relationship between immune-mediated inflammatory diseases and dyslipidemia, the underlying mechanisms contributing to atherogenesis, and the impact of various pharmacotherapies on lipid profiles and cardiovascular risk. We also discuss the role of lipid-lowering therapies, particularly statins, in managing residual risk in this high-risk population and explore the potential of emerging therapies with complementary anti-inflammatory and lipid-lowering effects. ahajournals.org/doi/full/10.… @society_eas @atvbahajournals
5
31
90
4,912
5
591
Dr. Michael Garshick retweeted
Important research by our cardio-rheumatology center @CleClinicHVTI
18 Nov 2024
Replying to @IssamMotairek
@IssamMotairek presenting “Sex Differences in CV mortality in Patients with Autoimmmune Disorders” @CleClinicHVTI @CCF_IMCHIEFS @LarsSvenssonMD @tavrkapadia #cardiorheumaology @HollandTamis Elaine Husni @CleClinicMD
3
7
59
7,589
Dr. Michael Garshick retweeted
Much to learn about relationship between Lp(a) & inflammation ?mechanisms ?impact on CVD risk. Pooled baseline data from phase 3 trials ⬆️ Lp(a) more prevalent in RA & psoriatic arthritis than ASCVD @Lpa_Doc @hsbhatia @PamTaubMD @DrMichaelShapir @garshick @Bweber04 @CBallantyneMD
.@MWilkinsonMD presenting work on Lp(a) levels in individuals with inflammatory diseases #AHA24 @UCSDCardFellows
1
6
40
1,876
Honored to work with this group and the AHA helping providers treat recurrent pericarditis! ⁦@Bweber04⁩ ⁦@nyulangone⁩ ⁦@NYUCVDPrevent⁩ ⁦@NYULHCVRC
1
1
24
2,222
Dr. Michael Garshick retweeted
Hanging at #AHA24 with the #Cardiorheumatology team for ⁦@ACCinTouch#CVPrev@EugeniaGianos⁩ ⁦@garshick⁩ ⁦@Bweber04⁩ ⁦@RonBlankstein
2
5
36
2,008
Happy to apart of this network. ⁦@AbbateAntonio⁩ ⁦@Bweber04⁩ ⁦@nyulangone⁩ ⁦@NYUCVDPrevent⁩ ⁦@NYULHCVRC
5
15
1,117
Great collaboration between cardiology, congenital cardiology, and ct surgery. ⁦@nyulangone⁩ ⁦@NYUCVDPrevent⁩ ⁦@NYULHCVRC
3
16
660
Dr. Michael Garshick retweeted
⏱️ Take a quick 15 on August 8 for this LIVE discussion that will connect the link between systemic inflammation, ASCVD, and CKD! Save the date to learn from @bweber04 @garshick. ➡️ ms.spr.ly/6010ljXbK
1
3
1,082